Irbesartan Pentafarma (Irbesartan)

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors located on blood vessels, the adrenal gland and renal tissue. This inhibition prevents angiotensin II‑mediated vasoconstriction and aldosterone release, resulting in vasodilation, reduced sodium and water retention, and ultimately lower blood pressure and renal protection.

The appropriate dose of Irbesartan Pentafarma is determined by a qualified prescriber based on the patient’s clinical condition, blood‑pressure response and any concomitant therapies. Physicians typically start with a low dose and may adjust it according to therapeutic goals and tolerability, following local prescribing guidelines.

Irbesartan falls under an unknown pregnancy category and is generally avoided during pregnancy because it may affect fetal development. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments with their healthcare provider, as safer options are usually preferred.

To order Irbesartan Pentafarma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers similar blood‑pressure control to ACE inhibitors but with a lower incidence of cough and angioedema. Both classes block the renin‑angiotensin system; however, ARBs like Irbesartan directly antagonize AT1 receptors, providing an alternative for patients intolerant to ACE inhibitors.

Irbesartan tablets should be stored at temperatures below 25 °C, in their original packaging, protected from moisture and direct light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments to maintain stability and potency.

Irbesartan is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare professional to maintain consistent blood‑pressure control.

Serious adverse events associated with Irbesartan include angioedema (swelling of the face, lips, tongue or throat), severe hypotension, acute renal failure, marked hyperkalemia, and rare cases of hepatic injury. Patients should seek immediate medical attention if they experience swelling, sudden dizziness, reduced urine output, or unexplained fatigue.

Irbesartan should not be used by individuals with known hypersensitivity to the drug or any ARB component. It is contraindicated in patients with severe hepatic impairment and should be avoided during pregnancy. Caution is also advised for patients with severe renal dysfunction or those taking potassium‑increasing medicines.